K220477 is an FDA 510(k) clearance for the Cellvizio 100 series system with confocal Miniprobes. This device is classified as a Confocal Optical Imaging (Class II - Special Controls, product code OWN).
Submitted by Mauna Kea Technologies (Paris, FR). The FDA issued a Cleared decision on April 11, 2022, 52 days after receiving the submission on February 18, 2022.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. Collection Of Light Signals For Visualization Of Cellular Microstructures..
| 510(k) Number | K220477 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 18, 2022 |
| Decision Date | April 11, 2022 |
| Days to Decision | 52 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | OWN - Confocal Optical Imaging |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 876.1500 |
| Definition | Collection Of Light Signals For Visualization Of Cellular Microstructures. |